Curated by
M-Bodied Coaching
M-Bodied Coaching is grounded in the principles and practices of Chi for Two®, a relational and developmental somatic method, also an ISMETA Approved Training Program. In-person Atlanta, Georgia. Virtually worldwide.
stacklist.com/mbodied_coaching
M-Bodied Coaching is grounded in the principles and practices of Chi for Two®, a relational and developmental somatic method, also an ISMETA Approved Training Program. In-person Atlanta, Georgia. Virtually worldwide.
More in Psychedelic Therapy & Integration
See all 6 →Somatic Therapy and Psychedelic Integration: Mind-Body Healing
psychedelic.support
Embodied Psychedelic Therapy: A Somatic Guide
manuelamischkereeds.com
OP-BRAI210411 1..16
More from M-Bodied Coaching
See all stacks →Parenting and Family Connection
5 cards · Parenting
Teen Development and Eating Disorder Recovery
2 cards · Wellness
Somatic Movement and Embodiment Practice
16 cards · Wellness
Psychedelic-assisted therapy: An overview for the internist
Psychedelic-assisted therapy, combining psychotherapy with compounds such as MDMA, psilocybin, and LSD, shows preliminary efficacy for depression, PTSD, and substance use disorders, with potential for durable effects after a single session. The article reviews therapeutic applications, safety profiles, pharmacologic mechanisms, and the current FDA regulatory landscape, urging internists to prepare for possible clinical integration.
Built for AI agentsACO · 11491 tokens
Summary
Psychedelic-assisted therapy, combining psychotherapy with compounds such as MDMA, psilocybin, and LSD, shows preliminary efficacy for depression, PTSD, and substance use disorders, with potential for durable effects after a single session. The article reviews therapeutic applications, safety profiles, pharmacologic mechanisms, and the current FDA regulatory landscape, urging internists to prepare for possible clinical integration.
Tags
psychedelic-assisted-therapy · psilocybin · mdma · psychiatry · clinical-trials · substance-use-disorders · ptsd
Key entities
Psychedelic-Assisted Therapy (concept, 0.99) · Psilocybin (technology, 0.97) · MDMA (technology, 0.97) · Lysergic Acid Diethylamide (LSD) (technology, 0.9) · US Food and Drug Administration (FDA) (organization, 0.98) · Posttraumatic Stress Disorder (PTSD) (concept, 0.93) · Serotonin 2A Receptor Agonism (concept, 0.85) · Set and Setting (concept, 0.8) · Ketamine (technology, 0.75)
Classification
reference · language en · status final
Provenance
claude-opus-4-6 via @stacklist/mcp-server@2.0.0, confidence 0.85, 23 Aug 2026